+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tapentadol"

From
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Tapentadol is an opioid analgesic used to treat moderate to severe pain. It is a centrally acting synthetic analgesic with a dual mechanism of action, acting on both the mu-opioid receptor and the norepinephrine reuptake inhibitor. Tapentadol is available in both immediate-release and extended-release formulations. It is used to treat a variety of conditions, including chronic pain, neuropathic pain, and post-operative pain. Tapentadol is generally well-tolerated and has fewer side effects than other opioids. Tapentadol is a relatively new analgesic on the market, but it has been gaining popularity due to its efficacy and safety profile. It is increasingly being used as an alternative to other opioids, such as oxycodone and hydrocodone. Tapentadol is also being used in combination with other analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs), to provide more effective pain relief. Some of the companies in the Tapentadol market include Grünenthal, Endo Pharmaceuticals, and Purdue Pharma. Grünenthal is the manufacturer of the brand name Tapentadol, while Endo Pharmaceuticals and Purdue Pharma both produce generic versions of the drug. Show Less Read more